ClinicalTrials.gg
TerminatedNCT03241433HALT-AFUpdated Nov 16, 2026

High-Intensity Aerobic Lifelong Training--AF

An interventional study of High intensity interval training and Moderate intensity continuous training in Atrial Fibrillation, sponsored by University of Minnesota. Terminated at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
Study stopped prematurely due to enrolment challenges and study funding ended
Updated Nov 16, 2026Now TerminatedEligibility revised+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 993 studies in Atrial Fibrillation with a site in United States — 160 open to participants now, 220 under way, 15 of them phase 3. Atrial Fibrillation · United States.

Enrollment
543rd of 679
27 · median 127
Started
2018
with 56 others
No phase
405 of 993
67 open now
Registered
491st of 993
by date

Among the 993 studies in Atrial Fibrillation with a site in United States, this one is the 543rd largest by enrollment of the 679 interventional ones that give a count, is one of 57 that started in 2018, is one of 405 with no phase, and was the 491st registered.

Atrial Fibrillation

4,018 studies on the registry are indexed under Atrial Fibrillation; 965 are open to participants now.

Browse Atrial Fibrillation studies →

Open to participants now

160 of the 993 studies in Atrial Fibrillation with a site in United States are open now. Recruiting first, the newest first:

155 more — sign in →

All 160 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 613 Atrial Fibrillation studies recruiting now, 410 (67%) set no upper age limit and 44 (7%) stop at 75 or younger; 21 take children under 18; 43 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 993 studies in Atrial Fibrillation with a site in United States, or all of them as a file.
02

Study summary

This study is a single-center RCT. Potential subjects with symptomatic non-permanent AF will be enrolled to determine the effect of sprint interval training (SIT) in comparison to moderate-intensity continuous training (MICT) and non-exercise control in reducing AF burden. The Investigators will enroll 60 patients during the first 12 months of the study. Baseline data collection will be conducted during the first month after enrollment. After baseline data collection, subjects will be randomized (1:1:1) to SIT vs. MICT vs. non-exercise controls. The exercise training will last for 3 months followed by final data collection which will be completed in 1 month.

Read the detailed description

Atrial fibrillation (AF) is the most common heart rhythm abnormality in the general population. Current recommended methods to maintain sinus rhythm or reduce AF burden (% time a person is in AF) in patients with non-permanent AF are costly and ineffective. Hence, there is an urgent need to discover novel inexpensive strategies to reduce AF burden. It is well-established that regular aerobic exercise reduces cardiovascular morbidity and mortality; however, adherence to regular exercise is poor rendering it an ineffective public health strategy. Evidence is emerging to suggest that traditional moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT) may be associated with lower AF burden. Compared with traditional MICT, HIIT is possibly more time-efficient; hence, it may promote adherence. Since lack of time is the most common reason for poor adherence to regular exercise, the time-efficiency of HIIT holds promise to be a "game-changer". However, many knowledge gaps remain. First, HIIT has never been compared directly with MICT in relation to AF burden; thus, whether HIIT is comparable or superior to MICT is unknown. Second, the time commitment required for a "conventional" HIIT program (120 mins/week) is not substantially less than the recommended MICT (150 mins/week); hence, it is doubtful that it can be a real "game-changer" in terms of promoting adherence. Third, HIIT performed using a cycle ergometer is a safer alternative to the treadmill in older adults, but has not been evaluated in patients with AF. Finally, mechanisms underlying the salutary benefits of exercise in relation to AF burden remain unknown. To address these knowledge gaps, the investigators will evaluate an innovative HIIT program-sprint interval training (SIT)-using a cycle ergometer that only requires 10 minutes per session and 30 minutes per week, in contrast to the "conventional" HIIT program that requires 40 minutes per session and 120 minutes per week. In this pilot randomized controlled trial (RCT), the investigators will randomize 60 subjects with non-permanent AF (1:1:1) to SIT vs. MICT vs. no exercise control. At enrollment, these subjects will undergo heart rhythm monitoring by a non-invasive ambulatory heart rhythm monitor, V02 max testing, assessment of cardiac size and function by cardiac MRI, and assessment of AF symptom severity; these measures will be repeated at 3 months.

03

Conditions studied

  • Atrial Fibrillation

Keywords

  • Exercise
04

Who can participate

The criteria were revised on the registry on Nov 16, 2026. See what changed

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with symptomatic non-permanent AF and aged 18-75 years who are sedentary (≤90 minutes/week of regular exercise)

Exclusion criteria

Exclusion Criteria:

  • Individuals lacking the capacity to consent for themselves will not be included, previous open heart surgery, \<45%, significant cardiac valve disease, coronary heart disease without complete revascularization, implanted cardiac electronic device, \<30 mL/min/1.73 m2, allergy to adhesive tape, or current smoking or regular smoking in the past 5 years.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Active comparator
    High intensity interval training

    Exercise training will be conducted 3 times per week using cycle ergometers at Fairview cardiac rehabilitation facilities for 12 weeks. Each session includes a 5-minute warmup and 5-minute cooldown at 50W. Intensity: Week 1 - 3 x 20-second sprint intervals at 50-60% peak power; Week 2 - 3 x 20-second sprint intervals at 60-70% peak power; Weeks 3-12 - 3 × 20-second sprint intervals at 90-95% peak power. Low intensity: 2 × 2-minute cycling at a slow pace at 50W between intervals. Total duration is 15 minutes per session and 45 minutes per week.

    Other: High intensity interval training

  • Active comparator
    Moderate intensity continuous training

    Exercise training will be conducted 3 times per week using cycle ergometers at Fairview cardiac rehabilitation facilities for 12 weeks. Each session includes a 5-minute warmup and 5-minute cooldown at 50W. Intensity: Week 1 - 20 minutes of continuous cycling at 30-40% peak workload; Week 2 - 20 minutes of continuous cycling at 45-60% peak workload; Weeks 3-12 - 45 minutes of continuous cycling at 45-60% peak workload. Total exercise time for MICT during weeks 1-2 was 30 minutes per session, 3 times a week for a total of 90 minutes. Total exercise time for MICT during weeks 3-12 was 55 minutes per session, 3 times a week for a total of 165 minutes per week.

    Other: Moderate intensity continuous training

  • Active comparator
    Yoga

    No excercise training will be done. Yoga will be done.

    Other: No Exercise

Interventions

  • OtherHigh intensity interval training

    exercise by use of stationary cycles

  • OtherModerate intensity continuous training

    exercise by use of stationary cycles

  • OtherNo Exercise

    no exercise training will be given and no exercise will be added to subjects routine

06

What researchers measure

Primary outcomes

  1. Change in AF burden

    After 12 weeks of exercise training , HIIT and MICT will be comparable but better than non-exercise control in AFburden(% of time a person is in AF) by using an ambulatory patch monitor

    Time frame: 3 months

Secondary outcomes

  1. Change in left atrial and left ventricular size and function

    After 12 weeks of exercise training HIIT and MICT will be comparable but better than non-exercise control as Cardiac MRI will be completed to assess LV and LA volumes and function and LV fibrosis

    Time frame: 3 months

  2. change in clinical outcomes

    The favorable effect of HIIT and MICT over non exercise control on clinical outcomes will be attenuated after after for secondary outcomes, suggesting that the latter mediate the clinical benefits of regular aerobic exercise

    Time frame: 3 months

07

Study locations

1 site
  • University of Minnesota
    Minneapolis, Minnesota 55455, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2018 to primary completion in Oct 2021, 41 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 27, 2017
First posted
Aug 7, 2017
StartActual
May 1, 2018
Primary completionActual
Oct 4, 2021
CompletionActual
Oct 4, 2021
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Completed→Terminated Study stopped prematurely due to enrolment challenges and study funding ended
changed Nov 16, 2026
Enrollment
60→27
Oct 28, 2026
Eligibility
Maximum age 65 Years→75 Years; 1 inclusion criterion edited; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • ChangedBefore : Patients with symptomatic non-permanent AF and aged 18-65 years who are sedentary (activity ≤0.5 hours/week of regular exercise) and seen by Dr. Chen or his cardiology colleagues at Clinics and Surgery Center (CSC), other Fairview cardiology clinics, and University of Minnesota Medical Center (UMMC). Patients will be screened and enrolled by a research coordinator.Now Patients with symptomatic non-permanent AF and aged 18-75 years who are sedentary (≤90 minutes/week of regular exercise)
Exclusion criteria
  • EditedIndividuals lacking the capacity to consent for themselves will not be included, previous open heart surgery, previous catheter ablation for AF, LVEF <45%, significant cardiac valve disease, coronary heart disease without complete revascularization, implanted cardiac electronic device, or GFR <30 mL/min/1.73 m2, allergy to adhesive tape, or current smoking or regular smoking in the past 5 years.
Nov 16, 2026
Interventions
Arm changed No exercise→Yoga
Nov 16, 2026
Show all 2 updates
  1. Nov 16, 2026
    Completed→Terminated
    Why stopped Study stopped prematurely due to enrolment challenges and study funding ended
    Eligibility Maximum age 65 Years→75 Years; 1 inclusion criterion edited; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • ChangedBefore : Patients with symptomatic non-permanent AF and aged 18-65 years who are sedentary (activity ≤0.5 hours/week of regular exercise) and seen by Dr. Chen or his cardiology colleagues at Clinics and Surgery Center (CSC), other Fairview cardiology clinics, and University of Minnesota Medical Center (UMMC). Patients will be screened and enrolled by a research coordinator.Now Patients with symptomatic non-permanent AF and aged 18-75 years who are sedentary (≤90 minutes/week of regular exercise)
    Exclusion criteria
    • EditedIndividuals lacking the capacity to consent for themselves will not be included, previous open heart surgery, previous catheter ablation for AF, LVEF <45%, significant cardiac valve disease, coronary heart disease without complete revascularization, implanted cardiac electronic device, or GFR <30 mL/min/1.73 m2, allergy to adhesive tape, or current smoking or regular smoking in the past 5 years.
    Interventions Arm changed No exercise→Yoga
    + 1 other change: verification date
  2. Oct 28, 2026
    Enrollment 60→27
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03241433
Responsible party
Sponsor
First posted
Aug 7, 2017
Start date
May 1, 2018
Primary completion
Oct 4, 2021
Completion
Oct 4, 2021
Last update
Nov 16, 2026

Study contacts

Lin Yee Chen, MD,MBBS,MS
principal investigator · University of Minnesota

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion